SifHansdottirMDPhD

Pulmonology • Iowa City, IA

Critical Care Medicine

Assistant Professor and Director, Pulmonary Hypertension Program, University of Iowa

Join to view full profile

Dr. Hansdottir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hansdottir's full profile

Already have an account?

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-4187

Fax+1 319-353-6406

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2001 - 2004
University of IcelandClass of 1998, MD

Certifications & Licensure

IA State Medical License 2008 - 2015

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
Completed
Phase 4
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

4 citations
[The impact of lung diseases, smoking and e-cigarette use on the severity of COVID-19 illness at diagnosis]
Gisli Thor Axelsson, Elias Eythorsson, Hronn Hardardottir, Gunnar Gudmundsson, Sif Hansdottir
Laeknabladid. 2020-12-01
49 citations
Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial
R. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda
American Journal of Respiratory and Critical Care Medicine. 2020-03-15
63 citations
Analysis of pulmonary features and treatment approaches in the COPA syndrome.
Jessica Tsui, Oscar A. Estrada, Zimu Deng, Kristin M. Wang, Christopher S. Law
ERJ Open Research. 2018-04-01